Home > Products > CA72-4 & CD3
> Human Anti-CA72-4 x Anti-CD3 Bispecific Antibody (IgG-IgG)
Human Anti-CA72-4 x Anti-CD3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H202)
Anti-CA72-4 x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CA72-4 and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
There are currently no customer reviews or questions for Human Anti-CA72-4 x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-H202). Click the button below to contact us or submit your feedback about this product.